Name: AURX Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: AURX, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does AURX have?

Accepted Answer

Nuo Therapeutics, Inc. (AURX) has 11 SEC Form 4 filings (20 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Aug 31, 2026.

Question 2

When was the most recent SEC Form 4 filing for AURX?

Accepted Answer

The most recent Form 4 filing for AURX on Tracefour is dated Aug 31, 2026.

Question 3

Who is the most active insider at AURX?

Accepted Answer

The most active SEC Form 4 filer at AURX in the rolling window is CEO/CFO JORDEN DAVID EMERSON, with 3 filings.

Question 4

What is the net insider flow at AURX over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at AURX have net bought $10K based on SEC Form 4 disclosures.

Question 5

What is the total insider buy and sell value at AURX in the current window?

Accepted Answer

Inside the rolling window, insiders at AURX bought $10K and sold $300K based on SEC Form 4 filings.

Question 6

Can I get alerts for AURX insider trading?

Accepted Answer

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Nuo Therapeutics, Inc. (AURX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

						Source
JORDEN DAVID EMERSONFirst in 9 months	CEO/CFO	Purchase	789	$844	Aug 31	SEC ↗
JORDEN DAVID EMERSONFirst in 9 months	CEO/CFO	Purchase	7,984	$9K	Aug 31	SEC ↗
JORDEN DAVID EMERSONFirst filing	CEO/CFO	Sale	200,000	$300K	Dec 3	SEC ↗

AURX

Related companies